Intrinsiqs

Is Gyre Therapeutics, Inc. overvalued?

Gyre Therapeutics, Inc. (GYRE) — key valuation metrics and fundamentals.

No verdict
Price
$4.31
Fair value
—
Current P/E
—
Normal P/E
—
Market cap
$471.7M
Dividend yield
0.0%
Return on equity
-22.4%
Sector
Healthcare

See the full interactive analysis →

Fair value compares GYRE's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.